Skip to main content
Equibles
CYTK logo

CYTK · Cytokinetics Inc · Held by Funds

Track CYTK — free

Use CYTK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CYTK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$56.13 -0.03 (-0.05%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$7.82B
Shares
139.30M
Volume · Nov 13 1.01M Avg daily vol (3M) 1.99M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of CYTK by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 24.16% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 4.07% 5,676,214
Index ETFs 20.09% 27,979,603
Active ETFs 1.38% 1,921,142
Active funds 29.42% 40,982,407
Unclassified 0.83% 1,159,667
All registered funds 55.79% 77,719,033
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding CYTK

555 fund positions
Fund Balance Value % of Fund Open
T. Rowe Price Capital Appreciation Fund 6,285,983 $535,502,892 0.76%
iShares Core S&P Mid-Cap ETF 4,646,338 $395,821,534 0.32%
VANGUARD TOTAL STOCK MARKET INDEX FUND 4,314,356 $367,539,988 0.02%
iShares Russell 2000 ETF 3,394,982 $289,218,517 0.35%
VANGUARD SMALL-CAP INDEX FUND 3,114,802 $265,349,982 0.14%
VANGUARD HEALTH CARE FUND 3,341,262 $257,711,538 0.68%
SMALLCAP World Fund Inc 2,997,051 $255,318,775 0.27%
Fidelity OTC Portfolio 2,269,700 $175,061,961 0.41%
T. Rowe Price Mid-Cap Growth Fund, Inc. 1,972,209 $168,012,485 0.73%
VANGUARD SMALL-CAP GROWTH INDEX FUND 1,793,318 $152,772,760 0.32%
VANGUARD EXTENDED MARKET INDEX FUND 1,557,317 $132,667,835 0.14%
State Street(R) SPDR(R) S&P(R) Biotech ETF 1,484,466 $126,461,659 1.18%
JNL/T. Rowe Price Capital Appreciation Fund 1,446,059 $123,189,766 0.81%
Fidelity Small Cap Index Fund 1,444,620 $111,423,541 0.33%
T. Rowe Price Capital Appreciation Equity ETF 1,160,888 $98,896,049 1.34%
T. Rowe Price Small-Cap Value Fund, Inc. 1,132,329 $96,463,108 0.91%
iShares Russell 2000 Value ETF 1,106,481 $94,261,116 0.65%
State Street SPDR S&P MidCap 400SM ETF Trust 1,044,627 $88,991,774 0.32%
iShares Biotechnology ETF 844,381 $71,932,817 0.79%
T. Rowe Price Small-Cap Stock Fund, Inc. 798,425 $68,017,826 0.73%
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF 687,229 $58,545,039 0.32%
VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO 650,234 $55,393,434 0.79%
Nomura Small Cap Core Fund 772,245 $54,759,893 1.05%
VANGUARD EXPLORER FUND 700,933 $54,062,962 0.24%
VANGUARD RUSSELL 2000 INDEX FUND 757,814 $53,736,591 0.30%
Invesco Discovery Fund 734,630 $52,092,613 0.70%
Eventide Healthcare & Life Sciences Fund 564,028 $48,049,545 2.69%
Fidelity Extended Market Index Fund 661,730 $46,923,274 0.12%
BlackRock Health Sciences Opportunities Portfolio 649,484 $46,054,910 0.72%
Schwab U.S. Small-Cap ETF 645,076 $45,742,339 0.20%
Penn Series Flexibly Managed Fund 464,608 $39,579,956 0.81%
T. Rowe Price Institutional Small-Cap Stock Fund 446,981 $38,078,311 0.76%
iShares S&P Mid-Cap 400 Growth ETF 437,723 $37,289,622 0.33%
JPMorgan Mid Cap Growth Fund 401,519 $34,205,404 0.26%
T. Rowe Price Health Sciences Fund, Inc. 395,436 $33,687,193 0.28%
SmallCap Fund 411,555 $31,743,237 1.52%
Small Cap Growth Fund 392,031 $30,237,351 0.54%
T. Rowe Price New Horizons Fund, Inc. 328,664 $27,998,886 0.19%
iShares S&P Mid-Cap 400 Value ETF 312,850 $26,651,692 0.31%
Schwab U.S. Mid-Cap ETF 375,558 $26,630,818 0.18%
Schwab Small-Cap Index Fund 321,227 $24,776,239 0.33%
Federated Hermes Kaufmann Fund 316,500 $24,411,645 0.50%
VANGUARD HEALTH CARE INDEX FUND 338,871 $24,029,343 0.11%
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund 262,777 $22,385,973 0.23%
JNL/Invesco Small Cap Growth Fund 259,218 $22,082,781 1.09%
Master Small Cap Index Series 243,853 $20,773,837 0.35%
VIP Growth Portfolio 237,000 $20,190,030 0.16%
Invesco Small Cap Growth Fund 232,463 $19,803,523 1.08%
Strategic Advisers U.S. Total Stock Fund 271,852 $19,277,025 0.02%
Hood River Small-Cap Growth Fund 225,014 $19,168,943 0.29%
Showing 1–50 of 555 positions
Key facts CIK 1061983 CUSIP 23282W605 13F (30d) 369 filings 332 filers Visit website Investor relations